Get the Stockscreener App
198.37
1.10%
2.16
After Hours:
198.90
0.53
+0.27%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $198.37, with a volume of 1.23M.
It is up +1.10% in the last 24 hours and up +19.91% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$196.21
Open:
$196.73
24h Volume:
1.23M
Relative Volume:
0.60
Market Cap:
$23.82B
Revenue:
$129.66B
Net Income/Loss:
$1.20B
P/E Ratio:
20.22
EPS:
9.8083
Net Cash Flow:
$375.00M
1W Performance:
-0.01%
1M Performance:
+19.91%
6M Performance:
-24.34%
1Y Performance:
-30.83%
1-Day Range:
$193.00
$198.74
1-Week Range:
$190.02
$201.79
52-Week Range:
$163.11
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
198.37 | 23.56B | 129.66B | 1.20B | 375.00M | 9.8083 |
UNH
Unitedhealth Group Inc
|
314.05 | 285.18B | 447.57B | 12.81B | 16.08B | 13.19 |
CVS
Cvs Health Corp
|
74.99 | 99.48B | 402.11B | 1.73B | 7.81B | 1.3835 |
CI
Cigna Group
|
268.63 | 71.87B | 274.88B | 6.29B | 8.39B | 22.19 |
ELV
Elevance Health Inc
|
311.18 | 68.83B | 199.13B | 5.66B | 3.17B | 25.11 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana declares quarterly dividend of $0.885 per share - Investing.com
Humana Board Declares Payment of Quarterly Dividend to Stockholders - Yahoo Finance
Analysts Cut Humana Price Target, Citing Competitive Pressures - National Today
How Humana’s Value-Based, Data-Driven Partnerships At Humana (HUM) Has Changed Its Investment Story - simplywall.st
Humana Price Target Cut by Analysts at Robert W. Baird - National Today
Nearly 40% misused COPD inhalers until phone coaching cut that below 7% - Stock Titan
Humana (NYSE:HUM) Price Target Cut to $205.00 by Analysts at Robert W. Baird - MarketBeat
Analyst recommendations: Alphabet, Citigroup, Cloudflare, Fair Isaac, Humana… - marketscreener.com
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Tuesday Health Partners with Humana on Palliative Care - Hospice News
Tuesday Health partners with Humana to expand palliative care in Texas - Investing.com India
Humana members in Texas get 24/7 palliative care support June 1 - Stock Titan
Robeco Institutional Asset Management B.V. Has $25.21 Million Position in Humana Inc. $HUM - MarketBeat
Sumitomo Mitsui Trust Group Inc. Purchases 59,199 Shares of Humana Inc. $HUM - MarketBeat
Humana Sets April 24 Date to Present First-Quarter 2026 Results - TipRanks
Handelsbanken raises Humana price target to SEK 50 (47), reiterates HoldBN - marketscreener.com
CVS Health Just Got a $13 Billion Reprieve. Here's Why the Stock Could Keep Climbing. - The Motley Fool
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana elects Robert S. Field to board - Medical Buyer
Humana Price Target Raised to $220 - National Today
Humana (NYSE:HUM) Price Target Raised to $220.00 - MarketBeat
High Ground Investment Management LLP Trims Position in Humana Inc. $HUM - MarketBeat
Humana adds veteran healthcare investor Robert Field to board - Insurance Business
Humana Elects Robert S. Field To Board Of Directors To Strengthen Healthcare Investment Expertise - Pulse 2.0
Is It Time To Reconsider Humana (HUM) After A 34% One Year Share Price Fall - simplywall.st
Humana and Thor hit the Casualty List, can revive and thrive Humana and Thor Hit the Casualty List - InsuranceNewsNet
Humana Adds Healthcare Investment Expert To Board As Valuation Draws Focus - Yahoo Finance
HUMHumana Announces Major Expansion of Florida Dental Network, Benefits - ADVFN
Pharma News: Is Humana Inc stock trending bullishPortfolio Risk Summary & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Humana adds healthcare investor Robert Field to board By Investing.com - Investing.com Australia
Humana Inc. $HUM Shares Purchased by Massachusetts Financial Services Co. MA - MarketBeat
Humana Inc. (HUM) Expands Board of Directors with New Appointmen - GuruFocus
Humana's Board Adds Investor Expert as Growth and Margin Battle Heats Up in 2026 - Bitget
Humana Elects Healthcare Investment Expert Robert S. Field to Board of Directors in 2026 - Minichart
Meta introduces prescription AI glasses, Gyde acquires Avid Health, b.well Connected Health partners with Noom, Welldoc, and Humana - VatorNews
Humana (HUM) Elects Robert Field to Board of Directors - GuruFocus
Humana Expands Board, Elects Robert Field as Director - TipRanks
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana (NYSE: HUM) adds healthcare investor Robert Field to its board - Stock Titan
Humana Elects Robert S. Field to Board of Directors - InsuranceNewsNet
Veteran healthcare investor Robert Field joins Humana's board - Stock Titan
Humana hires chief technology officer - The Business Journals
3 Health Insurance Stocks to Play On the Medicare Hike - Benzinga
Can UnitedHealth Ease Margin Pressure on CMS Tailwinds? - TradingView — Track All Markets
UnitedHealth Rockets 11%, Humana Climbs 9% as Medicare Advantage Rate Decision Crushes Regulatory Fears - AOL.com
Humana Is Still A Hold Despite The Medicare Advantage Rate Boost (NYSE:HUM) - Seeking Alpha
bwell Connected Health Platform Integrated by Humana for Member Data Access - TipRanks
Medicare Advantage "Relief Rally": Humana and UnitedHealth Surge as CMS Finalizes 2.48% Rate Increase for 2027 - FinancialContent
b.well announces partnerships with Noom, Humana, Welldoc - MobiHealthNews
Research Alert: CFRA Maintains Hold Rating On Shares Of Humana Inc. - 富途牛牛
Humana and UnitedHealth Surge as Medicare Advantage Payments Ris - GuruFocus
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.91%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):